Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice

American Journal of Pathology

Volumn 152, Issue 2, 1998, Pages 391-398

  Messing, Albee ^a   Head, Mark W ^b   Galles, Kevin ^a   Galbreath, Elizabeth J ^a   Goldman, James E ^b   Brenner, Michael ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Columbia Univ Coll Phys Surgs ^*  (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT SHOCK PROTEIN; MESSENGER RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN DISEASE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION; GLIOSIS; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; BRAIN DISEASES; CRYSTALLINS; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYPERTROPHY; INCLUSION BODIES; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; RNA, MESSENGER;

EID: 0031931614     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Eddleston M, Mucke L: Molecular profile of reactive astrocytes: implications for their role in neurologic disease. Neuroscience 1993, 54:15-36
2. Eng LF, Ghirnikar RS: GFAP and astrogliosis. Brain Pathol 1994, 4:229-237
3. Reier PJ, Houle JD, Tessler A, Jakeman L: Astrogliosis and regeneration: new perspectives to an old hypothesis. The Biochemical Pathology of Astrocytes. Edited by Norenberg MD, Hertz L, Schousboe A. New York, Alan R Liss, 1988, pp 107-122
4. Weinstein DE, Shelanski ML, Liem RKH: Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol 1991, 112:1205-1213
5. Rutka JT, Smith SL: Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity. Cancer Res 1993, 53:3624-3631
6. Chen W-J, Liem RKH: Reexpression of glial fibrillary acidic protein rescues the ability of astrocytoma cells to form processes in response to neurons. J Cell Biol 1994, 127:813-823
7. Gomi H, Yokoyama T, Fujimoto K, Ideka T, Katoh A, Itoh T, Itohara S: Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 1995, 14:29-41
8. Pekny M, Levéen P, Pekna M, Eliasson C, Berthold C-H, Westermark B, Betsholtz C: Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J 1995, 14:1590-1598
9. McCall MA, Gregg RG, Behringer RR, Brenner M, Delaney CL, Galbreath EJ, Zhang CL, Pearce RA, Chiu SY, Messing A: Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc Natl Acad Sci USA 1996, 93:6361-6366
10. Liedtke W, Edelmann W, Bieri PL, Chiu FC, Cowan NJ, Kucherlapati R, Raine CS: GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 1996, 17:607-615
11. Shibuki K, Gomi H, Chen L, Bao SW, Kim JSK, Wakatsuki H, Fujisaki T, Fujimoto J, Katoh A, Ikeda T, Chen C, Thompson RF, Itohara S: Deficient cerebellar long-term depression, impaired eyeblink conditioning, and normal motor coordination in GFAP mutant mice. Neuron 1996, 16:587-599
12. Brenner M, Lampel K, Nakatani Y, Mill J, Banner C, Mearow K, Dohadwala M, Lipsky R, Freese E: Characterization of human cDNA and genomic clones for glial fibrillary acidic protein. Mol Brain Res 1990, 7:277-286
13. Pleasure SJ, Lee VMY, Nelson DL: Site-specific phosphorylation of the middle molecular weight human neurofilament protein in transfected non-neuronal cells. J Neurosci 1990, 10:2428-2437
14. Chiu FC, Goldman JE: Synthesis and turnover of cytoskeletal proteins in cultured astrocytes. J Neurochem 1984, 42:166-174
15. Head MW, Corbin E, Goldman JE: Overexpression and abnormal modification of the stress proteins alpha B-crystallin and HSP27 in Alexander disease. Am J Pathol 1993, 143:1743-1753
16. Goldman JE, Corbin E: Rosenthal fibers contain ubiquitinated alpha B-crystallin. Am J Pathol 1991, 139:933-938
17. Head MW, Hurwitz L, Goldman JE: Transcriptional regulation of αB-crystallin in astrocytes: analysis of HSF and AP1 activation by different types of physiological stress. J Cell Sci 1996, 109:1029-1039
18. O'Callaghan JP: Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol Teratol 1991, 13:275-281
19. Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A: GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 1994, 14:1030-1037
20. Brenner M, Messing A: GFAP transgenic mice. Methods Companion Methods Enzymol 1996, 10:351-364
21. Duckett S, Goldman JE: Alexander's disease. Pediatric Neuropathology. Edited by Duckett S. Baltimore, Williams and Wilkins, 1995, pp 620-624
22. Johnson AB: Alexander's Disease. Neurodystrophies and Neurolipidoses. Edited by Moser HG. Amsterdam, Elsevier, 1996, pp 701-710
23. Herndon RM, Rubinstein LJ, Freeman JM, Mathieson G: Light and electron microscopic observations on Rosenthal fibers in Alexander's disease and in multiple sclerosis. J Neuropathol Exp Neurol 1970, 29:524-551
24. Iwaki T, Kume-Iwaki A, Liem RKH, Goldman JE: αB-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell 1989, 57:71-78
25. Iwaki T, Iwaki A, Tateishi J, Sakaki Y, Goldman JE: Alpha B-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Pathol 1993, 143:487-495
26. Ochi N, Kobayashi K, Maehara M, Nakayama A, Negoro T, Shinohara H, Watanabe K, Nagatsu T, Kato K: Increment of alpha B-crystallin mRNA in the brain of patient with infantile type Alexander's disease. Biochem Biophys Res Commun 1991, 179:1030-1035
27. Brenner M: Structure and transcriptional regulation of the GFAP gene. Brain Pathol 1994, 4:245-257
28. Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, Billett M, Landon M, Mayer RJ: Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibers in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 1988, 155:9-15
29. Hazan R, Denk H, Franke WW, Lackinger E, Schiller DL: Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody. Lab Invest 1986, 54:543-553
30. Fidzianska A, Goebel HH, Osborn M, Lenard HG, Osse G, Langenbeck U: Mallory-body-like inclusions in a hereditary congenital neuromuscular disease. Muscle Nerve 1983, 6:195-200
31. Bergeron C, Dickson DW, Pollanen MS: Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993, 52:183-191